ReviewJournal for immunotherapy of cancer2019

State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019.

Richard Lemal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.